Literature DB >> 1423597

Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins.

H Matsushime1, M E Ewen, D K Strom, J Y Kato, S K Hanks, M F Roussel, C J Sherr.   

Abstract

Murine D type cyclins associate with a catalytic subunit (p34PSK-J3) with properties distinct from known cyclin-dependent kinases (cdks). Mouse p34PSK-J3 shows less than 50% amino acid identity to p34cdc2, p33cdk2, and p36cdk3, lacks a PSTAIRE motif, and does not bind to p13suc1. Cyclin D1-p34PSK-J3 complexes accumulate in macrophages during G1 and decline in S phase, whereas complexes involving cyclins D2 and D3 form in proliferating T cells. Although histone H1 kinase activity is not detected in cyclin D or PSK-J3 immunoprecipitates, cyclin D-p34PSK-J3 complexes assembled in vitro stably bind and phosphorylate the retinoblastoma gene product (pRb) and an Rb-like protein (p107) but do not interact with pRb mutants that are functionally inactive. Thus, p34PSK-J3 is a cyclin D-regulated catalytic subunit that acts as an Rb (but not H1) kinase.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1423597     DOI: 10.1016/0092-8674(92)90360-o

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  253 in total

1.  Accumulation of cyclin E is not a prerequisite for passage through the restriction point.

Authors:  S V Ekholm; P Zickert; S I Reed; A Zetterberg
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

2.  The murine gammaherpesvirus 68 v-cyclin gene is an oncogene that promotes cell cycle progression in primary lymphocytes.

Authors:  L F van Dyk; J L Hess; J D Katz; M Jacoby; S H Speck; I V Virgin HW
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

3.  Overexpression of p27(KIP1) induced cell cycle arrest in G(1) phase and subsequent apoptosis in HCC-9204 cell line.

Authors:  Jiang Li; Xin-Ke Yang; Xin-Xin Yu; Meng-Liang Ge; Wen-Liang Wang; Jie Zhang; Yun-De Hou
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

Review 4.  Integration of the pRB and p53 cell cycle control pathways.

Authors:  C L Stewart; A M Soria; P A Hamel
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

5.  Decreased level of PDCD4 (programmed cell death 4) protein activated cell proliferation in the lung of A/J mouse.

Authors:  Soon-Kyung Hwang; Arash Minai-Tehrani; Hwang-Tae Lim; Ji-Young Shin; Gil-Hwan An; Kee-Ho Lee; Kee-Rang Park; Yeon-Soo Kim; George R Beck; Hsin-Sheng Yang; Myung-Haing Cho
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2010-10       Impact factor: 2.849

6.  Mechanism of cytotoxic action of crambescidin-816 on human liver-derived tumour cells.

Authors:  J A Rubiolo; H López-Alonso; M Roel; M R Vieytes; O Thomas; E Ternon; F V Vega; L M Botana
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

7.  The structure of CDK4/cyclin D3 has implications for models of CDK activation.

Authors:  T Takaki; A Echalier; N R Brown; T Hunt; J A Endicott; M E M Noble
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

Review 8.  Cell cycle, CDKs and cancer: a changing paradigm.

Authors:  Marcos Malumbres; Mariano Barbacid
Journal:  Nat Rev Cancer       Date:  2009-03       Impact factor: 60.716

9.  In vivo proliferation of differentiated pancreatic islet beta cells in transgenic mice expressing mutated cyclin-dependent kinase 4.

Authors:  S Hino; T Yamaoka; Y Yamashita; T Yamada; J Hata; M Itakura
Journal:  Diabetologia       Date:  2004-10-06       Impact factor: 10.122

10.  Function of a human cyclin gene as an oncogene.

Authors:  P W Hinds; S F Dowdy; E N Eaton; A Arnold; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.